[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@ZaiLab_Global Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1250704375288180736.png) @ZaiLab_Global Zai Lab

Zai Lab posts on X about london, the first the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1250704375288180736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1250704375288180736/c:line/m:interactions.svg)

- X Month XXX -XX%
- X Months XXXXX +1.50%
- X Year XXXXX -XX%

### Mentions: X [#](/creator/twitter::1250704375288180736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1250704375288180736/c:line/m:posts_active.svg)

- X Month X -XX%
- X Months XX +36%
- X Year XX -XX%

### Followers: XXX [#](/creator/twitter::1250704375288180736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1250704375288180736/c:line/m:followers.svg)

- X Month XXX +1.60%
- X Months XXX +13%
- X Year XXX +23%

### CreatorRank: undefined [#](/creator/twitter::1250704375288180736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1250704375288180736/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[travel destinations](/list/travel-destinations)  XX%

**Social topic influence**
[london](/topic/london) 20%, [the first](/topic/the-first) XX%

**Top accounts mentioned or mentioned by**
[@qimingvc](/creator/undefined) [@financialtimes](/creator/undefined) [@phoenix3million](/creator/undefined) [@prismmarketview](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"#NEWS: Zai Lab will deliver an oral presentation featuring updated data from our global Phase X trial of zocilurtatug pelitecan (ZL-1310) at the upcoming 2025 AACR-NCI-EORTC Conference in Boston. Visit: #ESSCLC #DLL3 #ADC #Targets25 #LungCancer"  
[X Link](https://x.com/ZaiLab_Global/status/1977793578689507787)  2025-10-13T17:48Z XXX followers, XXX engagements


"#NEWS: Zai Lab announces updated data from the global Ph1 clinical trial of zocilurtatug pelitecan (zoci)formerly ZL-1310 today at the AACR-NCI-EORTC International Conference. Learn more about the initiation of our global Ph3 Registrational Study: #ADC"  
[X Link](https://x.com/ZaiLab_Global/status/1981717775258161237)  2025-10-24T13:41Z XXX followers, XXX engagements


"#NEWS: Zai Lab announces third quarter 2025 financial results along with recent product highlights and corporate updates. Learn more about our pipeline progress and healthcare innovation: #earnings #financialresults #oncology #ADC #healthcare #innovation"  
[X Link](https://x.com/ZaiLab_Global/status/1986405834956423377)  2025-11-06T12:10Z XXX followers, XX engagements


"Zai Lab's President and COO Josh Smiley spoke at @FinancialTimes Global Pharma and Biotech Summit in London today on a panel discussing China's transformation into a biopharma innovation powerhouse. #FTPharma #Innovation #Biotech #BioPharma"  
[X Link](https://x.com/ZaiLab_Global/status/1988342614295220626)  2025-11-11T20:26Z XXX followers, XX engagements


"#NEWS: Zai Lab dosed the first participant in our Global Phase 1/1b study of ZL-1503 a potential first-in-class IL-13/IL-31R bispecific antibody for the treatment of atopic dermatitis. Discover the potential of ZL-1503:"  
[X Link](https://x.com/ZaiLab_Global/status/1998037695826674157)  2025-12-08T14:31Z XXX followers, XX engagements